57 related articles for article (PubMed ID: 11688402)
1. Tuberous sclerosis complex: multisystem hamartomas.
Naderi N; Timofte I; McCurdy MT; Reed RM
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25618887
[No Abstract] [Full Text] [Related]
2. Complete inactivation of the TSC2 gene leads to formation of hamartomas.
Au KS; Hebert AA; Roach ES; Northrup H
Am J Hum Genet; 1999 Dec; 65(6):1790-5. PubMed ID: 10577937
[No Abstract] [Full Text] [Related]
3. Tuberous sclerosis complex: A multisystem disorder.
Notaro K; Pierce B
JAAPA; 2021 Mar; 34(3):28-33. PubMed ID: 33528170
[TBL] [Abstract][Full Text] [Related]
4. The Clinical and Paraclinical Manifestations of Tuberous Sclerosis in an Omani Female Patient.
Al-Kharusi S; Al-Khatri S
Sultan Qaboos Univ Med J; 2024 Feb; 24(1):139-140. PubMed ID: 38434455
[No Abstract] [Full Text] [Related]
5. Early therapeutic intervention guided by electroencephalography surveillance in infants with tuberous sclerosis complex.
Jóźwiak S
Dev Med Child Neurol; 2024 May; 66(5):556-557. PubMed ID: 37941131
[No Abstract] [Full Text] [Related]
6. The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.
Curatolo P; Bjørnvold M; Dill PE; Ferreira JC; Feucht M; Hertzberg C; Jansen A; Jóźwiak S; Kingswood JC; Kotulska K; Macaya A; Moavero R; Nabbout R; Zonnenberg BA
Drugs; 2016 Apr; 76(5):551-65. PubMed ID: 26927950
[TBL] [Abstract][Full Text] [Related]
7. Subependymal giant cell astrocytoma: current concepts, management, and future directions.
Ouyang T; Zhang N; Benjamin T; Wang L; Jiao J; Zhao Y; Chen J
Childs Nerv Syst; 2014 Apr; 30(4):561-70. PubMed ID: 24549759
[TBL] [Abstract][Full Text] [Related]
8. Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation.
Michelozzi C; Di Leo G; Galli F; Silva Barbosa F; Labriola F; Sardanelli F; Cornalba G
Childs Nerv Syst; 2013 Feb; 29(2):249-54. PubMed ID: 22936080
[TBL] [Abstract][Full Text] [Related]
9. The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.
Moavero R; Pinci M; Bombardieri R; Curatolo P
Childs Nerv Syst; 2011 Aug; 27(8):1203-10. PubMed ID: 21305305
[TBL] [Abstract][Full Text] [Related]
10. Renal manifestation of tuberous sclerosis complex.
Bissler JJ; Christopher Kingswood J
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):338-347. PubMed ID: 30307110
[TBL] [Abstract][Full Text] [Related]
11. The kidney in the tuberous sclerosis complex.
Torres VE; King BF; Holley KE; Blute ML; Gomez MR
Adv Nephrol Necker Hosp; 1994; 23():43-70. PubMed ID: 8154365
[No Abstract] [Full Text] [Related]
12. Update on tuberous sclerosis complex.
Torres VE; King BF; McKusick MA; Bjornsson J; Zincke H
Contrib Nephrol; 2001; (136):33-49. PubMed ID: 11688402
[No Abstract] [Full Text] [Related]
13. Renal manifestations of tuberous sclerosis complex.
Torres VE; Zincke H; King BK; Bjornsson J
Contrib Nephrol; 1997; 122():64-75. PubMed ID: 9399042
[No Abstract] [Full Text] [Related]
14. Tuberous sclerosis complex renal disease.
Dixon BP; Hulbert JC; Bissler JJ
Nephron Exp Nephrol; 2011; 118(1):e15-20. PubMed ID: 21071977
[TBL] [Abstract][Full Text] [Related]
15. Two different types of renal involvement in tuberous sclerosis complex.
Scolari F; Viola BF; Grazioli L; Longa L; Migone N; Maiorca R
Contrib Nephrol; 2001; (136):318-24. PubMed ID: 11688400
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
